Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies

Bobbak Vahid; Paul E Marik

doi:10.1155/2008/305234

Canadian Respiratory Journal (Jan 2008)

Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies

Bobbak Vahid,
Paul E Marik

Affiliations

Bobbak Vahid: Dominican Hospital, Santa Cruz Pulmonary Medical Group, Santa Cruz, California, USA
Paul E Marik: Thomas Jefferson University Hospital, Department of Pulmonary and Critical Care Medicine, Philadelphia, Pennsylvania, USA

DOI: https://doi.org/10.1155/2008/305234
Journal volume & issue: Vol. 15, no. 4
pp. 211 – 216

Abstract

Read online

Infiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments. The present review discusses different pulmonary syndromes, pathogenesis and management of these novel agents.

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/7503

About the journal